Concussion Global Market Report 2025

A concussion refers to a form of traumatic brain injury (TBI) resulting from a sudden impact or force to the head or body, leading to the rapid movement of the brain within the skull. This condition can cause temporary impairment of brain function and disrupt normal neurological activities.

Concussion assessments primarily revolve around diagnosis and treatment. Diagnosis involves identifying the medical condition or injury through a comprehensive assessment of symptoms, medical history, and various diagnostic tests. These tests often include imaging tools such as magnetic resonance imaging (MRI), X-rays, computed tomography (CT), as well as monitoring devices and other diagnostic equipment. These assessments are utilized by a range of healthcare facilities such as hospitals, clinics, diagnostic centers, and medical camps to evaluate and manage concussions.

The concussion market research report is one of a series of new reports from The Business Research Company that provides concussion market statistics, including the concussion industry's global market size, regional shares, competitors with a concussion market share, detailed concussion market segments, market trends and opportunities, and any further data you may need to thrive in the concussion industry. This concussion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The concussion market size has grown steadily in recent years. It will grow from $7.97 billion in 2024 to $8.22 billion in 2025 at a compound annual growth rate (CAGR) of 3.3%. The growth in the historic period can be attributed to increased awareness and education, sports participation and injuries, stringent sports regulations, advancements in diagnostic tools, and legal and ethical implications

The concussion market size is expected to see steady growth in the next few years. It will grow to $9.94 billion in 2029 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to the continued focus on sports safety, research and development in treatment, increased adoption of concussion protocols, growing public health concerns, and collaboration between medical and sports communities. Major trends in the forecast period include teleconcussion services and remote monitoring, educational initiatives for concussion prevention, research on long-term effects and chronic traumatic encephalopathy (CTE), implementation of concussion protocols in sports organizations, development of neuroprotective therapies, legislation, and regulations for concussion management.

The growth of the concussion market is anticipated to be propelled by an increase in the prevalence of brain injuries. Brain injuries encompass a range of damages affecting the brain, resulting in diverse physical, cognitive, and emotional impairments. Timely and appropriate treatment of concussions is crucial for mitigating the impact of brain-related injuries on overall brain health. This involves practices such as physical and cognitive rest, symptom management, and a gradual return to activities. The escalation in traffic accidents has also contributed to the higher incidence of brain injuries. According to a January 2023 article from the National Center for Biotechnology Information (NCBI), an estimated 1.7 million people in the United States experience traumatic brain injuries annually, with individuals aged 15 to 19 and seniors aged 65 and older facing the highest risk. Moreover, primary malignant tumors of the brain and spinal cord are expected to impact thousands of people in the US. Consequently, the increasing prevalence of brain injuries is a key driver of the concussion market.

The growth trajectory of the concussion market is further expected to be influenced by the rise in the prevalence of neurological diseases. Neurological diseases constitute a diverse range of medical conditions affecting the nervous system, encompassing the brain, spinal cord, and peripheral nerves. Traumatic brain injuries, often involving concussions, are significant contributors to the initiation, exacerbation, or complications of various neurological diseases such as chronic traumatic encephalopathy (CTE) or post-concussion syndrome. As of February 2023, the World Health Organization (WHO) reports that epilepsy, a neurological disease, affects approximately 5 million people globally. High-income countries witness 49 cases per 100,000 individuals, while low- and middle-income countries experience up to 139 cases per 100,000. The prevalence of neurological diseases, therefore, plays a pivotal role in driving the growth of the concussion market.

Product innovation stands out as a prominent trend shaping the landscape of the concussion market. Leading companies in this market are directing their efforts towards developing innovative products to enhance their diagnostic capabilities and maintain a competitive edge. One notable example is TecTraum Inc., a US-based medical device designer, and Nottingham-Spirk Design Associates Inc., a US-based product design firm, who collaborated to introduce pro2cool in May 2022. Recognized as the world's first point-of-care treatment for concussions, pro2cool is a groundbreaking noninvasive hypothermic treatment device. Engineered to alleviate the severity of concussion symptoms, it aims to expedite patients' recovery to their pre-injury baseline. The device achieves this by locally cooling the head and neck, thereby lowering blood temperature before it reaches the brain. Clinical investigations have shown promising results, indicating significant improvements in clinical outcomes when the brain is cooled within days following a concussion.

Major players are embracing strategic partnerships as a proactive approach to raise awareness about the gravity of concussions. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefits and success. An illustrative instance of such collaboration is the partnership between Abbott Laboratories, a US-based medical device company, and the Brain Injury Association of America (BIAA), a US-based national organization. Formed in December 2022, this alliance aims to heighten awareness about the seriousness of concussions and emphasize the importance of seeking care for potential concussions. The coalition, comprising nearly twenty advocacy groups, addresses the alarming fact that more than half of individuals suspecting a concussion fail to seek medical evaluation. This strategic collaboration is positioned to play a crucial role in raising public consciousness about concussion-related issues.

In August 2023, Oxeia Biopharmaceuticals Inc., a clinical-stage biotech company based in the United States, successfully acquired SUN11031, a synthetic human ghrelin compound, from Kinemed Inc., another U.S.-based pharmaceutical research and development firm. The financial details of this transaction were not disclosed. This strategic acquisition by Oxeia Biopharmaceuticals aims to leverage SUN11031, which will be developed under the designation OXE103, as a potential treatment for concussions and acute neurotrauma.

Major companies operating in the concussion market include Pfizer Inc., Novartis AG, Sanofi SA, Abbott Laboratories, Medtronic plc, Viatris Inc., Zydus Lifesciences Ltd., Integra LifeSciences Corporation, Nihon Kohden Corporation, Raumedic AG, Lupin Limited, NeuroPace Inc., Compumedics Limited, NeuroLogica Corporation, Neural Analytics Inc., NovaSignal Corp., Back Bay Life Science Advisors, BrainScope Company Inc., Neuro Kinetics Inc., ImPACT Applications Inc., NanoDx Inc., Neuren Pharmaceuticals Limited, Advanced Brain Monitoring Inc., ElMindA Ltd., NeurOptics Inc., InfraScan Inc., Neuro Assessment Systems Inc., NeuroTrauma Sciences LLC, SyncThink Inc., Oxeia Biopharmaceuticals Inc., Oculogica Inc., Banyan Biomarkers Inc., Emotiv Inc., BioDirection Inc., Neurologic Wellness Institute

North America was the largest region in the concussion market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the concussion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the concussion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The concussion market consists of revenues earned by entities by providing concussion services such as consultations, diagnostic tests, imaging studies, CT scans, MRIs, and specialized diagnostic tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The concussion market also includes sales of medications such as pain relievers, anti-nausea medication, or drugs targeting sleep disturbances or mood disorders. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Concussion Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on concussion market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for concussion ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The concussion market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Assessment: Diagnosis; Treatment
• 2) By Device: Imaging Devices; Magnetic Resonance Imaging (MRI) Devices; X-Ray; Computed Tomography; Monitoring Devices; Other Devices
• 3) By End User: Hospitals And Clinics; Diagnostic Centers; Medical Camps; Other End-Users
• Subsegments:
• 1) By Diagnosis: Clinical Assessments; Imaging Techniques
• 2) By Treatment: Pharmacological Treatments; Cognitive Rehabilitation; Physical Therapy
• Companies Mentioned: Pfizer Inc.; Novartis AG; Sanofi SA; Abbott Laboratories; Medtronic plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.